Treatment of seasonal allergic rhinitis in patients ≥6 years old and perennial allergic rhinitis in patients ≥12 years old. Omnaris is an alcohol-free, hypotonic suspension formulation of the ...
In a large-scale Phase III study, OMNARIS delivered in an aerosol nasal formulation propelled by HFA (hydrofluoroalkane) met both its primary and key secondary endpoints MARLBOROUGH, Mass., Apr 27, ...
Patients Taking ZETONNA Report Improved Quality Of Life Measures (RQLQ[S]) Associated With Seasonal Allergic Rhinitis MARLBOROUGH, Mass., Jul 30, 2012 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. ...
FRANKFURT, Oct 23 (Reuters) - German drugs and chemicals group Altana has received U.S. approval for its ciclesonide nasal spray to treat symptoms of seasonal and perennial allergic rhinitis in ...
Sunovion Pharmaceuticals Inc. (Sunovion) today announced the nationwide availability of ZETONNA™ (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results